Which forms should i complete for lipitor's program?

What forms are needed for Lipitor patient assistance

Pfizer's Lipitor patient assistance program uses a single combined application. Patients complete the Pfizer Patient Assistance Program Application and attach proof of income and residency. The form asks for household income, insurance status, and prescription details. No separate enrollment or renewal form is required for the initial request.

What information must be on the application

Applicants list all household members and their incomes, provide a copy of the most recent tax return or pay stubs, and confirm they lack coverage through Medicaid, Medicare Part D, or private insurance that pays for Lipitor. The physician section requires the doctor's signature, NPI number, and the exact prescription details.

When to submit the application

Submit the form before the current supply runs out. Pfizer processes most applications in 5–10 business days once all documents are received. If approval is granted, medication ships directly to the patient or prescriber at no cost.

How long approval lasts

Approved patients receive medication for up to 12 months. Renewal requires a new application and updated income documents each year. Coverage can end earlier if the patient gains insurance that covers Lipitor.

What happens if the application is denied

Common reasons for denial include income above the program threshold, existing insurance that covers the drug, or missing documents. Patients denied for income reasons may reapply after a change in household income or explore state pharmacy assistance programs.

Can biosimilars or generic atorvastatin be obtained through the program

The Pfizer program supplies only brand-name Lipitor. Generic atorvastatin is widely available at low cost through retail pharmacies or discount programs and is not part of this assistance pathway.

When does Lipitor patent exclusivity end

Lipitor's U.S. patent and regulatory exclusivity expired in 2011, allowing generic atorvastatin to launch immediately. No remaining patent barriers affect patient-assistance eligibility for the brand product.

Sources
1. Pfizer Patient Assistance Program Application Form
2. DrugPatentWatch.com